Epigenetic repression of miR‐375 is the dominant mechanism for constitutive activation of the <scp>PDPK</scp>1/<scp>RPS</scp>6<scp>KA</scp>3 signalling axis in multiple myeloma
Shotaro Tatekawa(Kyoto Prefectural University of Medicine), Junya Kuroda(Kyoto Prefectural University of Medicine), Masaki Ri(Nagoya University Hospital), Tsutomu Kobayashi(Kyoto first Red Cross hospital), Yayoi Matsumura‐Kimoto(Kyoto Prefectural University of Medicine), Eri Kawata(Panasonic (Japan)), Hiroshi Handa(Gunma University), Taku Tsukamoto(Kyoto Prefectural University of Medicine), Yoshiaki Chinen(Kyoto Prefectural University of Medicine), Shinsuke Iida(Nagoya City University Hospital), Tomohiko Taki(Kyorin University), Tomoko Narita(Nagoya City University), Yuji Shimura(Kyoto Prefectural University of Medicine), Masafumi Taniwaki(Kyoto Prefectural University), Nobuhiko Uoshima(Matsushita Memorial Hospital)
Cited by 26
Related Papers
Adenoviral E1A-Associated Protein p300 Is Involved in Acute Myeloid Leukemia With t(11; 22)(q23; q13)
|Blood|1997|262
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
|The Lancet Haematology|2019|247